Literature DB >> 12603530

Effects of insulin-like growth factors-IR and -IIR antisense gene transfection on the biological behaviors of SMMC-7721 human hepatoma cells.

Jian-Min Yang1, Wen-Sheng Chen, Zhi-Peng Liu, Yuan-Hui Luo, Wei-Wen Liu.   

Abstract

BACKGROUND AND AIMS: Insulin-like growth factors (IGFs) are closely related to hepatocellular carcinoma growth. The study aim was to investigate the effects of IGF-IR and IGF-IIR antisense gene transfection on the biological behaviors of SMMC-7721 human hepatoma cells.
METHODS: 7721-IGF-IR-AS cells (human hepatoma SMMC-7721 cells transfected with IGF-IR antisense gene in our previous study) were transfected with a plasmid vector expressing IGF-IIR cDNA in the antisense orientation by DOTAP liposome.7721-IGF-R-AS cells were obtained by selection with G418 and hygromycin. Morphological changes of the cells were observed with optic and electron microscopes. In vitro growth of the 7721-IGF-R-AS cells was observed with a soft agar test, MTT test and with naked mice inoculation test in vivo.
RESULTS: The following changes were found in the SMMC-7721 cells after being transfected with the IGF-IR and IGF-IIR antisense genes: (i) the degree of malignancy of the tumor cells as revealed by cell morphology was ameliorated; (ii) the growth capability of the tumor cells in soft agar and their tumorigenicity in naked mice were significantly depressed. However, in the control groups, the SMMC-7721 cells transfected both with IGF-IR and IGF-IIR sense cDNA and SMMC-7721 cells transfected without any external genes, had no such changes. However, the cell growth curves had no significant differences among these three groups.
CONCLUSION: IGF-IR and IGF-IIR antisense genes could significantly restrain the malignant behavior of human hepatoma cells and might be useful in investigating a potential route for hepatocellular carcinoma gene therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12603530     DOI: 10.1046/j.1440-1746.2003.02961.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin.

Authors:  Yuting Kuang; Anthony El-Khoueiry; Pietro Taverna; Mats Ljungman; Nouri Neamati
Journal:  Mol Oncol       Date:  2015-06-16       Impact factor: 6.603

Review 2.  Molecular therapies in hepatocellular carcinoma: what can we target?

Authors:  Roberto Galuppo; Dinesh Ramaiah; Oscar Moreno Ponte; Roberto Gedaly
Journal:  Dig Dis Sci       Date:  2014-02-27       Impact factor: 3.199

3.  Effects of KAI1 gene on growth and invasion of human hepatocellular carcinoma MHCC97-H cells.

Authors:  Sui-Hai Si; Jian-Min Yang; Zhi-Hong Peng; Yuan-Hui Luo; Ping Zhou
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

4.  Systemically identifying and prioritizing risk lncRNAs through integration of pan-cancer phenotype associations.

Authors:  Chaohan Xu; Rui Qi; Yanyan Ping; Jie Li; Hongying Zhao; Li Wang; Michael Yifei Du; Yun Xiao; Xia Li
Journal:  Oncotarget       Date:  2017-02-14

5.  Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer.

Authors:  Hui Kong; Ying Wu; Mengou Zhu; Changwen Zhai; Jing Qian; Xue Gao; Shuyang Wang; Yingyong Hou; Shaohua Lu; Hongguang Zhu
Journal:  Oncotarget       Date:  2016-08-02

6.  Identification and characterization of the lncRNA signature associated with overall survival in patients with neuroblastoma.

Authors:  Srinivasulu Yerukala Sathipati; Divya Sahu; Hsuan-Cheng Huang; Yenching Lin; Shinn-Ying Ho
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

7.  In silico regulatory analysis for exploring human disease progression.

Authors:  Dustin T Holloway; Mark Kon; Charles DeLisi
Journal:  Biol Direct       Date:  2008-06-18       Impact factor: 4.540

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.